SABRA HEALTH CARE REIT INC. overview

Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the second quarter of 2023. SECOND QUARTER 2023 RESULTS AND RECENT EVENTS Results per diluted common share for the second quarter of 2023 were as follows: Net Income: $0.09 FFO: $0.32 Normalized FFO: $0.33 AFFO: $0.33 Normalized AFFO: $0.34 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.65x (1.57x excluding Provider Relief Funds) Senior Housing -...

Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2023 second quarter earnings release on August 7, 2023, after the close of trading. A conference call with a simultaneous webcast to discuss the 2023 second quarter results will be held on Tuesday, August 8 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL...

Sabra Health Care REIT, Inc. (“Sabra,” or “we”) (Nasdaq: SBRA) today released its third annual Sustainability Report. The report showcases our programs, policies and initiatives that support our environmental, social and governance (ESG) priorities of environmental stewardship; diversity, equity and inclusion; human capital management; protection of health, wellness and safety of our stakeholders; engagement and collaboration with our operators and tenants; cybersecurity; corporate...

Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company’s Chair and Chief Executive Officer, Michael Costa, the company’s Chief Financial Officer, Talya Nevo-Hacohen, the company’s Chief Investment Officer, and Lukas Hartwich, the company’s Senior Vice President of Finance, will participate in Nareit’s REITweek 2023 Investor Conference June 6 - 8, 2023 at the New York Hilton Midtown. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation,...

Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the first quarter of 2023. FIRST QUARTER 2023 RESULTS AND RECENT EVENTS Results per diluted common share for the first quarter of 2023 were as follows: Net Loss: $(0.04) FFO: $0.32 Normalized FFO: $0.33 AFFO: $0.33 Normalized AFFO: $0.34 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.63x 1.55x (excluding Provider Relief Funds “PRF”) - up from...

Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2023 first quarter earnings release on May 3, 2023, after the close of trading. A conference call with a simultaneous webcast to discuss the 2023 first quarter results will be held on Thursday, May 4 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is...

Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the fourth quarter of 2022. FOURTH QUARTER 2022 RESULTS AND RECENT EVENTS Results per diluted common share for the fourth quarter of 2022 were as follows: Net Loss: $(0.37) FFO: $0.25 Normalized FFO: $0.37 AFFO: $0.34 Normalized AFFO: $0.37 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.77x (pro forma for North American transition, Avamere lease...

Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company’s Chair and Chief Executive Officer, will present at the WISE Forum, and other members of the company will attend the WISE Forum on February 28, 2023, at the Rancho Valencia Resort and Spa in Rancho Santa Fe, California. Additionally, Rick Matros, Talya Nevo-Hacohen, the company’s Chief Investment Officer, Darrin Smith, the company’s Executive Vice President of Investments, and other members of the...